| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 2023 | Oct 17, 2023 | Tango Therapeutics, Inc. | Other | Buy | 96.3 | +1,250,000 | 8.53% | ✗ | $8.7M |
| Oct 13, 2023 | Oct 17, 2023 | Tango Therapeutics, Inc. | Other | Buy | 96.3 | +1,250,000 | 8.53% | ✗ | $8.7M |
| Oct 9, 2023 | Oct 11, 2023 | Tango Therapeutics, Inc. | Other | Sell | 17.5 | -225,000 | -2.86% | ✗ | $2.2M |
| Aug 11, 2023 | Aug 15, 2023 | Tango Therapeutics, Inc. | Other | Buy | 95.0 | +475,000 | 6.43% | ✗ | $2.4M |
| Oct 11, 2022 | Oct 13, 2022 | Tango Therapeutics, Inc. | 10% Owner | Buy | 92.5 | +237,000 | 3.21% | ✗ | $1M |
| Oct 4, 2022 | Oct 6, 2022 | Tango Therapeutics, Inc. | 10% Owner | Buy | 90.0 | +182,000 | 2.65% | ✗ | $714.1K |
| Dec 17, 2021 | Dec 21, 2021 | Tyra Biosciences, Inc. | 10% Owner | Buy | 87.5 | +125,000 | 1.98% | ✗ | $1.6M |
| Sep 17, 2021 | Sep 17, 2021 | Tyra Biosciences, Inc. | 10% Owner | Buy | 100.0 | +625,000 | 10.97% | ✗ | $10M |
| Sep 25, 2020 | Sep 29, 2020 | PMV Pharmaceuticals, Inc. | Other | Buy | 100.0 | +950,000 | 100.00% | ✗ | $17.1M |
| Dec 19, 2018 | Dec 20, 2018 | INSEEGO CORP. | 10% Owner | Buy | 100.0 | +9,752,729 | 107.81% | ✗ | $29.3M |
| Nov 2, 2018 | Nov 5, 2018 | Esperion Therapeutics, Inc. | 10% Owner | Sell | 16.3 | -100,000 | -8.32% | ✗ | $5.6M |
| Jun 13, 2016 | Jun 14, 2016 | Carisma Therapeutics Inc. | 10% Owner | Sell | 17.5 | -1,042,000 | -38.16% | ✗ | $2.9M |